ROFERON-A 4.5MUI / 0.5ml injectible solution medication leaflet

L03AB04 interferon alfa 2A • Antineoplastic and immunomodulating agents | Immunostimulants | Interferons

Interferon alfa-2A is a medication used for the treatment of viral infections, such as chronic hepatitis B and C, and certain types of cancer, such as leukemia. It works by stimulating the immune response and inhibiting viral replication.

The medication is administered as a subcutaneous or intramuscular injection, as directed by a doctor, usually several times a week. It is important for patients to follow the treatment regimen and undergo regular check-ups.

Patients should be aware of potential side effects, such as flu-like symptoms, fatigue, or depression. It is important to inform the doctor of any unusual symptoms.

Common side effects include flu-like symptoms, fatigue, and depression. In rare cases, severe reactions such as liver impairment or hematologic disorders may occur. Patients should be informed of these risks before starting treatment.

General data about ROFERON-A 4.5MUI / 0.5ml

Substance: interferon alfa 2A

Date of last drug list: 01-07-2013

Commercial code: W08778001

Concentration: 4.5MUI / 0.5ml

Pharmaceutical form: injectible solution

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for interferon alfa 2A

18MUI/0.6ml, 3MUI/0.5ml, 4.5MUI/0.5ml, 6MUI/0.5ml, 9MUI/0.5ml